Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alivecor, Innovative Health, Teoxane, Vy Spine.

Biopharma happenings, including deals and partnerships, and other news in brief: Alloy, BCM, Domain, Eisai, Formosa, Johnson & Johnson, Link Cell, Lyra, Metagenomi, Nuvation Bio, Radius Health, Samil, Swiss Rockets, Vaximm.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Arrowhead Pharmaceutical, Ark Biopharmaceutical, GSK, Kelun-Biotech, Scinopharm, Takeda, Vivavision, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Hutchmed, Incyte Biosciences, Kahr Medical, Nanjing Delova Biotech

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Acepodia, Axion Bio, Biocytogen, Cyrora, Cytoreason, Daiichi Sankyo, Dexcel, Orexo, Evogene, Foresee, Genesis Pharma, Halozyme, Hatchtech, Immuneonco, Instil Bio, Made Scientific, Medlink Therapeutics, Nxera, Ono Pharmaceutical Pelthos, Organon, Primavera Therapeutics, Roche, Sanofi, Santhera, Scenic Biotech, Takeda, Unravel, Zeo Scientific.

Biopharmas in Asia-Pacific raising money in public or private financings: Ribo Life Science.

New hires and promotions in the med-tech industry, including: Biolojic Design, Nuevocor, Orum, Vaxxas.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Alessa, Aquestive, Kezar, PDS, Uniqure.

Biopharma happenings, including deals and partnerships, and other news in brief: Acepodia, Anaptys, Avista, Biocytogen, Cytoreason, Dewpoint, GSK, Iktos, Link Cell Therapies, Madrigal, Medilink, Nona, Pfizer, Pierre, Roche, Sanofi, Tesaro.